68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

NARecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

July 30, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Carbonic Anhydrase IXPET-CTClear Cell Renal Cell Carcinoma

Interventions

DRUG

68Ga-C1

68Ga-C1 is injected intravenously with a dose of 0.05-0.10 mCi/kg

Trial Locations (1)

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Peking University First Hospital

OTHER